261 related articles for article (PubMed ID: 34994851)
1. Innovative therapeutic concepts of progressive multifocal leukoencephalopathy.
Möhn N; Grote-Levi L; Hopfner F; Eiz-Vesper B; Maecker-Kolhoff B; Warnke C; Sühs KW; Wattjes MP; Höglinger GU; Skripuletz T
J Neurol; 2022 May; 269(5):2403-2413. PubMed ID: 34994851
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
3. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy therapy.
Clifford DB
J Neurovirol; 2015 Dec; 21(6):632-6. PubMed ID: 25227934
[TBL] [Abstract][Full Text] [Related]
6. Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility?
Jelcic I; Combaluzier B; Jelcic I; Sospedra M; Grimm J; Martin R
Swiss Med Wkly; 2017; 147():w14520. PubMed ID: 29120025
[TBL] [Abstract][Full Text] [Related]
7. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.
Seth P; Diaz F; Major EO
J Neurovirol; 2003 Apr; 9(2):236-46. PubMed ID: 12707854
[TBL] [Abstract][Full Text] [Related]
8. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.
Corey S; Smith BR; Cortese ICM
Curr HIV/AIDS Rep; 2022 Dec; 19(6):580-591. PubMed ID: 36181625
[TBL] [Abstract][Full Text] [Related]
9. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
Beck ES; Cortese I
Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
[TBL] [Abstract][Full Text] [Related]
10. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
Bauer J; Gold R; Adams O; Lassmann H
Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
[TBL] [Abstract][Full Text] [Related]
11. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Kishida S
No To Shinkei; 2007 Feb; 59(2):125-37. PubMed ID: 17315754
[TBL] [Abstract][Full Text] [Related]
12. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
Medrano C; Vergez F; Mengelle C; Faguer S; Kamar N; Del Bello A
Emerg Infect Dis; 2019 Nov; 25(11):2145-2147. PubMed ID: 31625858
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
[TBL] [Abstract][Full Text] [Related]
15. JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.
Van Loy T; Thys K; Ryschkewitsch C; Lagatie O; Monaco MC; Major EO; Tritsmans L; Stuyver LJ
J Virol; 2015 Jan; 89(2):1340-7. PubMed ID: 25392214
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy - epidemiology, immune response, clinical differences, treatment.
Snopková S; Štourač P; Fašaneková L; Mihalčin M; Havlíčková K; Svačinka R; Volfová P; Snopek P; Husa P
Epidemiol Mikrobiol Imunol; 2019; 68(1):24-31. PubMed ID: 31181949
[TBL] [Abstract][Full Text] [Related]
17. Update on progressive multifocal leukoencephalopathy.
Steiner I; Berger JR
Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
[TBL] [Abstract][Full Text] [Related]
18. Progressive Multifocal Leukoencephalopathy.
Grebenciucova E; Berger JR
Neurol Clin; 2018 Nov; 36(4):739-750. PubMed ID: 30366552
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
Shishido-Hara Y
Neuropathology; 2015 Oct; 35(5):487-96. PubMed ID: 25946231
[TBL] [Abstract][Full Text] [Related]
20. [Progressive multifocal leukoencephalopathy].
Moulignier A; Lecler A; Lamirel C
Rev Prat; 2016 Feb; 66(2):185-190. PubMed ID: 30512335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
